Suppr超能文献

六西格玛在评估血浆蛋白分析性能及设计基于风险的统计质量控制策略中的应用:一项多中心研究

The Application of Six Sigma to Assess the Analytical Performance of Plasma Proteins and Design a Risk-Based Statistical Quality Control Strategy: A Multicenter Study.

作者信息

Hu Ming, Wang Jiaping, Yang Huan, Zang Sugang, Gao Tingting, Zeng Jian, Yang Fumeng

机构信息

Department of Laboratory Medicine, People's Hospital of Donghai County, Lianyungang, People's Republic of China.

Department of Laboratory Medicine, The Second Affiliated Hospital of Suzhou University, Suzhou, People's Republic of China.

出版信息

J Clin Lab Anal. 2025 Aug;39(16):e70080. doi: 10.1002/jcla.70080. Epub 2025 Jul 18.

Abstract

BACKGROUND

This study applied the six sigma model to evaluate plasma protein testing performance in six laboratories, with customized quality control programs and targeted improvements introduced where necessary.

METHODS

Internal quality control (IQC) and external quality assessment (EQA) data for plasma proteins were gathered from six laboratories. Sigma values for each analyte were determined based on the coefficient of variation (CV), bias, and total allowable error (TEa). Using six sigma performance verification charts, we calibrated analyte performance and, guided by Westgard sigma rules, batch length, and quality goal index (QGI), developed laboratory-specific quality control schemes and improvement plans.

RESULTS

Despite standardized platforms and reagents, sigma values showed significant inter-laboratory variation, with some differences also observed within labs at varying analyte concentrations. For projects with sigma < 6, tailored quality control measures were implemented, leading to marked performance improvements.

CONCLUSION

The six sigma model provides an objective framework for evaluating plasma protein test performance and enhancing quality. It enables quantitative assessment of laboratory management and supports the development and implementation of customized, risk-based statistical quality control (SQC) strategies and improvement measures across multiple laboratory systems.

摘要

背景

本研究应用六西格玛模型评估六个实验室的血浆蛋白检测性能,必要时引入定制的质量控制程序并进行针对性改进。

方法

收集六个实验室的血浆蛋白内部质量控制(IQC)和外部质量评估(EQA)数据。根据变异系数(CV)、偏差和总允许误差(TEa)确定每种分析物的西格玛值。使用六西格玛性能验证图,我们校准了分析物性能,并以西加德西格玛规则、批次长度和质量目标指数(QGI)为指导,制定了特定实验室的质量控制方案和改进计划。

结果

尽管平台和试剂标准化,但西格玛值显示出显著的实验室间差异,在不同分析物浓度下,各实验室内部也观察到一些差异。对于西格玛值<6的项目,实施了定制的质量控制措施,从而显著提高了性能。

结论

六西格玛模型为评估血浆蛋白检测性能和提高质量提供了一个客观框架。它能够对实验室管理进行定量评估,并支持在多个实验室系统中制定和实施定制的、基于风险的统计质量控制(SQC)策略及改进措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e14/12378367/e22d918e474d/JCLA-39-e70080-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验